Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

PHASE4RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 13, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

March 31, 2031

Conditions
Kidney TransplantationMycophenolate Mofetil
Interventions
DRUG

Mycophenolate Mofetil (MMF) Maintenance Group

Mycophenolate Mofetil (MMF), administered orally as standard of care post kidney transplant as part of their immunosuppression regimen. Maintenance in Immunosuppression medication.

DRUG

Mycophenolate Mofetil (MMF) Withdrawal Group

Mycophenolate Mofetil (MMF), administered orally as standard of care post kidney transplant as part of their immunosuppression regimen. Withdrawal of MMF immunosuppression medication.

Trial Locations (3)

32224

RECRUITING

Mayo Clinic, Jacksonville

55905

RECRUITING

Mayo Clinic, Rochester

85054

RECRUITING

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Transplant Genomics, Inc.

INDUSTRY

collaborator

Eurofins

INDUSTRY

lead

Mayo Clinic

OTHER

NCT06568549 - Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. | Biotech Hunter | Biotech Hunter